title: Higher urinary potassium is associated with decreased stone growth after shock wave lithotripsy.
abstract: OBJECTIVE
  We correlated serum and urinary biochemical parameters with radiological evidence of stone growth after shock wave lithotripsy.
  
  
  METHODS
  Biochemical parameters in serum and 24-hour urine collections of 359 patients were correlated with stone growth for 2 years after shock wave lithotripsy. Each patient underwent a minimum of 2 radiological studies at 3 and 12 months and plain abdominal x-ray at 24 months. The presence and size of stones were documented by a radiologist in blinded fashion. Stone growth was defined as measurable growth of a preexisting stone or new stone formation.
  
  
  RESULTS
  A total of 209 patients remained stone-free or had no existing stone growth, while stone size decreased in 30. Of the remaining 120 patients with stone growth 72 had new growth and 48 had growth of preexisting stones. Urinary excretion of potassium was significantly higher in those without than with stone growth (mean 24-hour urine collection plus or minus standard deviation 62 +/- 27 versus 54 +/- 23 mmol., p = 0.009). The only parameter significantly associated with stone growth was urinary potassium. Linear regression revealed that for each 10 unit increase in urinary potassium there was a corresponding 2 mm. decrease in stone growth (p = 0.013).
  
  
  CONCLUSIONS
  Our results indicate that increased urinary potassium excretion correlates with a decreased risk of stone growth up to 2 years after shock wave lithotripsy, implying that a high potassium diet may be beneficial for preventing stone growth. The effect of potassium supplementation on stone formation and growth must be investigated further.
authors.affiliation: Department of Medicine, Humber River Regional Hospital, Toronto, Ontario, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Pierratos
authors.forename: N
authors.initials: N
authors.lastname: Dharamsi
authors.forename: L K
authors.initials: LK
authors.lastname: Carr
authors.forename: D
authors.initials: D
authors.lastname: Ibanez
authors.forename: M A
authors.initials: MA
authors.lastname: Jewett
authors.forename: R J
authors.initials: RJ
authors.lastname: Honey
mesh_terms: D019587:Dietary Supplements; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy / Q000652:urine*; D016014:Linear Models; D008096:Lithotripsy; D008297:Male; D011188:Potassium / Q000652:urine*; D017419:Potassium, Dietary / Q000627:therapeutic use; D011446:Prospective Studies; D011859:Radiography; D014514:Ureteral Calculi / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy / Q000652:urine*
chemical_list: D017419:Potassium, Dietary; D011188:Potassium